Filing metadata

Accession number
0001209191-22-021624
Form type
Form 4
Filer
ENDRA Life Sciences Inc.
CIK
CIK 1681682
Filed
Mar 30, 2022
Reporting period
Mar 28, 2022
Description
Insider transaction

Explore SEC Filings Hub